{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:09:56Z","timestamp":1788887396753,"version":"build-2803163510"},"reference-count":72,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_med-2026-1479_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) is a highly aggressive brain cancer. Golgi dysfunction plays a role in tumorigenesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1479_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study analyzed the role of Golgi apparatus-related genes (GARGs) in GBM using bioinformatics. Prognostic genes were identified using differential expression, Cox, and Lasso analyses. A prognostic model and nomogram were constructed based on gene expression and clinical characteristics. Immune infiltration and drug sensitivity analyses were performed in different risk groups. Reverse transcription quantitative PCR (RT-qPCR) was employed to explore the expression of prognostic\u00a0genes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1479_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5 prognostic genes (CD14, FMOD, LGR6, SLC16A13, and KDELR2) of GBM were identified, and on the basis of the prognostic genes, a prognostic model was built. There was a significant survival difference between patients in the high and low risk groups for GBM. Receiver operating characteristic (ROC) curve indicated that the predictive effect of the prognostic model in the training set was moderate, with an AUC value of around 0.7. The nomogram showed that risk score had a better predictive effect than age. Drug sensitivity analysis demonstrated that sorafenib was more sensitive in the low-risk group of GBM. RT-qPCR results revealed that compared with the control group, the expression levels of CD14 and SLC16A13 were significantly downregulated in GBM cell lines, while FMOD and LGR6 were markedly upregulated. The expression of KDELR2 exhibited obvious cell line-dependent variation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_med-2026-1479_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, this study establishes a Golgi apparatus-related gene signature that not only offers prognostic insights but may also informs tailored therapeutic strategies for GBM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2026-1479","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:58:01Z","timestamp":1788886681000},"source":"Crossref","is-referenced-by-count":0,"title":["A novel prognostic model based on Golgi apparatus-related genes predicts patient survival in glioblastoma"],"prefix":"10.1515","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1918-1932","authenticated-orcid":false,"given":"Hongliu","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youkun","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjiang","family":"Cui","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kedong","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Stomatology , The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Department of General Practice , Wuhan , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofen","family":"Bo","sequence":"additional","affiliation":[{"name":"Department of General Practice , The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology Department of General Practice , Wuhan , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5122-9272","authenticated-orcid":false,"given":"Li","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery , The Second People\u2019s Hospital of Jing Zhou & The Affiliated Hospital of Hubei College of Chinese Medicine , Jing Zhou , Hubei Province , PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"2026090816575600841_j_med-2026-1479_ref_001","doi-asserted-by":"crossref","unstructured":"Kristensen, BW, Priesterbach-Ackley, LP, Petersen, JK, Wesseling, P. Molecular pathology of tumors of the central nervous system. Ann Oncol 2019;30:1265\u201378. https:\/\/doi.org\/10.1093\/annonc\/mdz164.","DOI":"10.1093\/annonc\/mdz164"},{"key":"2026090816575600841_j_med-2026-1479_ref_002","unstructured":"Hanif, F, Muzaffar, K, Perveen, K, Malhi, SM, Simjee, SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev APJCP 2017;18:3\u20139. https:\/\/doi.org\/10.22034\/apjcp.2017.18.1.3."},{"key":"2026090816575600841_j_med-2026-1479_ref_003","doi-asserted-by":"crossref","unstructured":"Stupp, R, Taillibert, S, Kanner, AA, Kesari, S, Steinberg, DM, Toms, SA, et al.. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA 2015;314:2535\u201343. https:\/\/doi.org\/10.1001\/jama.2015.16669.","DOI":"10.1001\/jama.2015.16669"},{"key":"2026090816575600841_j_med-2026-1479_ref_004","unstructured":"Khosla, D. Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma. Ann Transl Med 2016;4:54. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2016.01.25."},{"key":"2026090816575600841_j_med-2026-1479_ref_005","doi-asserted-by":"crossref","unstructured":"Cesarini, V, Silvestris, DA, Tassinari, V, Tomaselli, S, Alon, S, Eisenberg, E, et al.. ADAR2\/miR-589-3p axis controls glioblastoma cell migration\/invasion. Nucleic Acids Res 2018;46:2045\u201359. https:\/\/doi.org\/10.1093\/nar\/gkx1257.","DOI":"10.1093\/nar\/gkx1257"},{"key":"2026090816575600841_j_med-2026-1479_ref_006","doi-asserted-by":"crossref","unstructured":"Sharma, A, Guerrero-C\u00e1zares, H, Maciaczyk, J. Editorial to special issue glioblastoma: recapitulating the key breakthroughs and future perspective. Int J Mol Sci 2023;24:2548. https:\/\/doi.org\/10.3390\/ijms24032548.","DOI":"10.3390\/ijms24032548"},{"key":"2026090816575600841_j_med-2026-1479_ref_007","doi-asserted-by":"crossref","unstructured":"Robilliard, LD, Yu, J, Anchan, A, Finlay, G, Angel, CE, Graham, ES. Comprehensive assessment of secreted immuno-modulatory cytokines by serum-differentiated and stem-like glioblastoma cells reveals distinct differences between glioblastoma phenotypes. Int J Mol Sci 2022;23:14164. https:\/\/doi.org\/10.3390\/ijms232214164.","DOI":"10.3390\/ijms232214164"},{"key":"2026090816575600841_j_med-2026-1479_ref_008","doi-asserted-by":"crossref","unstructured":"Fan, W, Yu, X, Li, K, Zhu, M. The alerting expression of microRNA-411 predicts clinical prognosis and regulates tumor progression of glioblastoma. Bioengineered 2021;12:8650\u20137. https:\/\/doi.org\/10.1080\/21655979.2021.1988365.","DOI":"10.1080\/21655979.2021.1988365"},{"key":"2026090816575600841_j_med-2026-1479_ref_009","doi-asserted-by":"crossref","unstructured":"Kulkarni-Gosavi, P, Makhoul, C, Gleeson, PA. Form and function of the Golgi apparatus: scaffolds, cytoskeleton and signalling. FEBS Lett 2019;593:2289\u2013305. https:\/\/doi.org\/10.1002\/1873-3468.13567.","DOI":"10.1002\/1873-3468.13567"},{"key":"2026090816575600841_j_med-2026-1479_ref_010","doi-asserted-by":"crossref","unstructured":"Liu, J, Huang, Y, Li, T, Jiang, Z, Zeng, L, Hu, Z. The role of the Golgi apparatus in disease (review). Int J Mol Med 2021;47:38. https:\/\/doi.org\/10.3892\/ijmm.2021.4871.","DOI":"10.3892\/ijmm.2021.4871"},{"key":"2026090816575600841_j_med-2026-1479_ref_011","doi-asserted-by":"crossref","unstructured":"Buzuk, L, Hellerschmied, D. Ubiquitin-mediated degradation at the Golgi apparatus. Front Mol Biosci 2023;10:1197921. https:\/\/doi.org\/10.3389\/fmolb.2023.1197921.","DOI":"10.3389\/fmolb.2023.1197921"},{"key":"2026090816575600841_j_med-2026-1479_ref_012","doi-asserted-by":"crossref","unstructured":"Martins, M, Fernandes, AS, Saraiva, N. GOLGI: cancer cell fate control. Int J Biochem Cell Biol 2022;145:106174. https:\/\/doi.org\/10.1016\/j.biocel.2022.106174.","DOI":"10.1016\/j.biocel.2022.106174"},{"key":"2026090816575600841_j_med-2026-1479_ref_013","doi-asserted-by":"crossref","unstructured":"Li, H, Zhang, P, Luo, J, Hu, D, Huang, Y, Zhang, ZR, et al.. Chondroitin sulfate-linked prodrug nanoparticles target the Golgi apparatus for cancer metastasis treatment. ACS Nano 2019;13:9386\u201396. https:\/\/doi.org\/10.1021\/acsnano.9b04166.","DOI":"10.1021\/acsnano.9b04166"},{"key":"2026090816575600841_j_med-2026-1479_ref_014","doi-asserted-by":"crossref","unstructured":"Tao, Y, Yang, Y, Zhou, R, Gong, T. Golgi apparatus: an emerging platform for innate immunity. Trends Cell Biol 2020;30:467\u201377. https:\/\/doi.org\/10.1016\/j.tcb.2020.02.008.","DOI":"10.1016\/j.tcb.2020.02.008"},{"key":"2026090816575600841_j_med-2026-1479_ref_015","doi-asserted-by":"crossref","unstructured":"Alhussen, A, Haq, MA, Khan, AA, Mahendran, RK, Kadry, S. XAI-RACapsNet: relevance aware capsule network-based breast cancer detection using mammography images via explainability O-net ROI segmentation. Expert Syst Appl 2025;261:14. https:\/\/doi.org\/10.1016\/j.eswa.2024.125461.","DOI":"10.1016\/j.eswa.2024.125461"},{"key":"2026090816575600841_j_med-2026-1479_ref_016","doi-asserted-by":"crossref","unstructured":"Tan, X, Banerjee, P, Pham, EA, Rutaganira, FUN, Basu, K, Bota-Rabassedas, N, et al.. PI4KIII\u03b2 is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med 2020;12:eaax3772. https:\/\/doi.org\/10.1126\/scitranslmed.aax3772.","DOI":"10.1126\/scitranslmed.aax3772"},{"key":"2026090816575600841_j_med-2026-1479_ref_017","doi-asserted-by":"crossref","unstructured":"Haqak, MIAAESM, Alshehri, A, Ghamry, NA. DCNNBT: a novel deep convolution neural network-based brain tumor classification model. Fractals 2023;31:2340102. https:\/\/doi.org\/10.1142\/s0218348x23401023.","DOI":"10.1142\/S0218348X23401023"},{"key":"2026090816575600841_j_med-2026-1479_ref_018","doi-asserted-by":"crossref","unstructured":"Ibrahim, M, Muhammad, Q, Zamarud, A, Eiman, H, Fazal, F. Navigating glioblastoma diagnosis and care: transformative pathway of artificial intelligence in integrative oncology. Cureus 2023;15:e44214. https:\/\/doi.org\/10.7759\/cureus.44214.","DOI":"10.7759\/cureus.44214"},{"key":"2026090816575600841_j_med-2026-1479_ref_019","doi-asserted-by":"crossref","unstructured":"Brown, ED, Pelcher, I, Leon, S, Karkare, AN, Barbero, JA, Ward, M, et al.. Artificial intelligence applications in the screening and classification of glioblastoma. J\u00a0Neurosurg Sci 2025;69:362\u201370. https:\/\/doi.org\/10.23736\/s0390-5616.25.06502-6.","DOI":"10.23736\/S0390-5616.25.06502-6"},{"key":"2026090816575600841_j_med-2026-1479_ref_020","doi-asserted-by":"crossref","unstructured":"Brindha, V, Jayashree, P, Karthik, P, Manikandan, P. Tumor grading model employing geometric analysis of histopathological images with characteristic nuclei dictionary. Comput Biol Med 2022;149:106008. https:\/\/doi.org\/10.1016\/j.compbiomed.2022.106008.","DOI":"10.1016\/j.compbiomed.2022.106008"},{"key":"2026090816575600841_j_med-2026-1479_ref_021","doi-asserted-by":"crossref","unstructured":"Zhang, J, Liu, J, Ding, R, Miao, X, Deng, J, Zhao, X, et al.. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma. 2024;16:5249\u201363. https:\/\/doi.org\/10.18632\/aging.205645.","DOI":"10.18632\/aging.205645"},{"key":"2026090816575600841_j_med-2026-1479_ref_022","doi-asserted-by":"crossref","unstructured":"Love, MI, Huber, W, Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","DOI":"10.1186\/s13059-014-0550-8"},{"key":"2026090816575600841_j_med-2026-1479_ref_023","doi-asserted-by":"crossref","unstructured":"Gu, Z. Complex heatmap visualization. iMeta 2022;1:e43. https:\/\/doi.org\/10.1002\/imt2.43.","DOI":"10.1002\/imt2.43"},{"key":"2026090816575600841_j_med-2026-1479_ref_024","doi-asserted-by":"crossref","unstructured":"Manzi, G, Spiegelhalter, DJ, Turner, RM, Flowers, J, Thompson, SG. Modelling bias in combining small area prevalence estimates from multiple surveys. J\u00a0R Stat Soc Ser A Stat Soc. 2011;174:31\u201350. https:\/\/doi.org\/10.1111\/j.1467-985X.2010.00648.x.","DOI":"10.1111\/j.1467-985X.2010.00648.x"},{"key":"2026090816575600841_j_med-2026-1479_ref_025","doi-asserted-by":"crossref","unstructured":"Wu, T, Hu, E, Xu, S, Chen, M, Guo, P, Dai, Z, et al.. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2021;2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141.","DOI":"10.1016\/j.xinn.2021.100141"},{"key":"2026090816575600841_j_med-2026-1479_ref_026","doi-asserted-by":"crossref","unstructured":"Zhang, H, Meltzer, P, Davis, S. RCircos: an R package for Circos 2D track plots. BMC Bioinf 2013;14:244. https:\/\/doi.org\/10.1186\/1471-2105-14-244.","DOI":"10.1186\/1471-2105-14-244"},{"key":"2026090816575600841_j_med-2026-1479_ref_027","doi-asserted-by":"crossref","unstructured":"Mayakonda, A, Lin, DC, Assenov, Y, Plass, C, Koeffler, HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 2018;28:1747\u201356. https:\/\/doi.org\/10.1101\/gr.239244.118.","DOI":"10.1101\/gr.239244.118"},{"key":"2026090816575600841_j_med-2026-1479_ref_028","doi-asserted-by":"crossref","unstructured":"Liu, G, Pan, Y, Li, Y, Xu, H. lncRNA and mRNA signature for prognosis prediction of glioblastoma. Future Oncol 2020;16:837\u201348. https:\/\/doi.org\/10.2217\/fon-2019-0538.","DOI":"10.2217\/fon-2019-0538"},{"key":"2026090816575600841_j_med-2026-1479_ref_029","doi-asserted-by":"crossref","unstructured":"Jamali, Z, Ghorbani, F, Shafie\u2019ei, M, Tolooefar, F, Maleki, E. Risk factors associated with vitamin D deficiency in preterm neonates: a single-center step-wise regression analysis. BMC Pediatr 2023;23:324. https:\/\/doi.org\/10.1186\/s12887-023-04088-w.","DOI":"10.1186\/s12887-023-04088-w"},{"key":"2026090816575600841_j_med-2026-1479_ref_030","doi-asserted-by":"crossref","unstructured":"Simon, N, Friedman, J, Hastie, T, Tibshirani, R. Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J\u00a0Stat Software 2011;39:1\u201313. https:\/\/doi.org\/10.18637\/jss.v039.i05.","DOI":"10.18637\/jss.v039.i05"},{"key":"2026090816575600841_j_med-2026-1479_ref_031","doi-asserted-by":"crossref","unstructured":"Zheng, Y, Wen, Y, Cao, H, Gu, Y, Yan, L, Wang, Y, et al.. Global characterization of immune infiltration in clear cell renal cell carcinoma. OncoTargets Ther 2021;14:2085\u2013100. https:\/\/doi.org\/10.2147\/ott.S282763.","DOI":"10.2147\/OTT.S282763"},{"key":"2026090816575600841_j_med-2026-1479_ref_032","doi-asserted-by":"crossref","unstructured":"Mao, YK, Liu, ZB, Cai, L. Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression. Oncol Lett 2020;20:1619\u201328. https:\/\/doi.org\/10.3892\/ol.2020.11729.","DOI":"10.3892\/ol.2020.11729"},{"key":"2026090816575600841_j_med-2026-1479_ref_033","doi-asserted-by":"crossref","unstructured":"H\u00e4nzelmann, S, Castelo, R, Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","DOI":"10.1186\/1471-2105-14-7"},{"key":"2026090816575600841_j_med-2026-1479_ref_034","doi-asserted-by":"crossref","unstructured":"Ritchie, ME, Phipson, B, Wu, D, Hu, Y, Law, CW, Shi, W, et al.. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","DOI":"10.1093\/nar\/gkv007"},{"key":"2026090816575600841_j_med-2026-1479_ref_035","doi-asserted-by":"crossref","unstructured":"Thorsson, V, Gibbs, DL, Brown, SD, Wolf, D, Bortone, DS, Ou Yang, TH, et al.. The immune landscape of cancer. Immunity 2018;48:812\u201330.e14. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023.","DOI":"10.1016\/j.immuni.2018.03.023"},{"key":"2026090816575600841_j_med-2026-1479_ref_036","doi-asserted-by":"crossref","unstructured":"Maeser, D, Gruener, RF, Huang, RS. oncoPredict: an R package for predicting in\u00a0vivo or cancer patient drug response and biomarkers from cell line screening data. Briefings Bioinf 2021;22:bbab260. https:\/\/doi.org\/10.1093\/bib\/bbab260.","DOI":"10.1093\/bib\/bbab260"},{"key":"2026090816575600841_j_med-2026-1479_ref_037","doi-asserted-by":"crossref","unstructured":"Deininger, MH, Meyermann, R, Schluesener, HJ. Expression and release of CD14 in astrocytic brain tumors. Acta Neuropathol 2003;106:271\u20137. https:\/\/doi.org\/10.1007\/s00401-003-0727-9.","DOI":"10.1007\/s00401-003-0727-9"},{"key":"2026090816575600841_j_med-2026-1479_ref_038","doi-asserted-by":"crossref","unstructured":"Prosniak, M, Harshyne, LA, Andrews, DW, Kenyon, LC, Bedelbaeva, K, Apanasovich, TV, et al.. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin Cancer Res 2013;19:3776\u201386. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-1940.","DOI":"10.1158\/1078-0432.CCR-12-1940"},{"key":"2026090816575600841_j_med-2026-1479_ref_039","doi-asserted-by":"crossref","unstructured":"Werneburg, S, Buettner, FF, Erben, L, Mathews, M, Neumann, H, M\u00fchlenhoff, M, et al.. Polysialylation and lipopolysaccharide-induced shedding of E-selectin ligand-1 and neuropilin-2 by microglia and THP-1 macrophages. Glia 2016;64:1314\u201330. https:\/\/doi.org\/10.1002\/glia.23004.","DOI":"10.1002\/glia.23004"},{"key":"2026090816575600841_j_med-2026-1479_ref_040","doi-asserted-by":"crossref","unstructured":"Latz, E, Visintin, A, Lien, E, Fitzgerald, KA, Monks, BG, Kurt-Jones, EA, et al.. Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J\u00a0Biol Chem 2002;277:47834\u201343. https:\/\/doi.org\/10.1074\/jbc.M207873200.","DOI":"10.1074\/jbc.M207873200"},{"key":"2026090816575600841_j_med-2026-1479_ref_041","doi-asserted-by":"crossref","unstructured":"Matveichuk, OV, Ciesielska, A, Hromada-Judycka, A, Nowak, N, Ben Amor, I, Traczyk, G, et al.. Flotillins affect LPS-induced TLR4 signaling by modulating the trafficking and abundance of CD14. Cell Mol Life Sci 2024;81:191. https:\/\/doi.org\/10.1007\/s00018-024-05221-3.","DOI":"10.1007\/s00018-024-05221-3"},{"key":"2026090816575600841_j_med-2026-1479_ref_042","doi-asserted-by":"crossref","unstructured":"Ru, P, Guo, D. microRNA-29 mediates a novel negative feedback loop to regulate SCAP\/SREBP-1 and lipid metabolism. RNA Dis 2017;4:e1525. https:\/\/doi.org\/10.14800\/rd.1525.","DOI":"10.14800\/rd.1525"},{"key":"2026090816575600841_j_med-2026-1479_ref_043","doi-asserted-by":"crossref","unstructured":"Arriagada, C, Cavieres, VA, Luchsinger, C, Gonz\u00e1lez, AE, Mu\u00f1oz, VC, Cancino, J, et al.. GOLPH3 regulates EGFR in T98G glioblastoma cells by modulating its glycosylation and ubiquitylation. Int J Mol Sci 2020;21:8880. https:\/\/doi.org\/10.3390\/ijms21228880.","DOI":"10.3390\/ijms21228880"},{"key":"2026090816575600841_j_med-2026-1479_ref_044","doi-asserted-by":"crossref","unstructured":"Chen, M, Ba, H, Lu, C, Dai, J, Sun, J. Glial cell line-derived neurotrophic factor (GDNF) promotes angiogenesis through the demethylation of the fibromodulin (FMOD) promoter in glioblastoma. Med Sci Monit 2018;24:6137\u201343. https:\/\/doi.org\/10.12659\/msm.911669.","DOI":"10.12659\/MSM.911669"},{"key":"2026090816575600841_j_med-2026-1479_ref_045","doi-asserted-by":"crossref","unstructured":"Cheng, YY, Yang, X, Gao, X, Song, SX, Yang, MF, Xie, FM. LGR6 promotes glioblastoma malignancy and chemoresistance by activating the Akt signaling pathway. Exp Ther Med 2021;22:1364. https:\/\/doi.org\/10.3892\/etm.2021.10798.","DOI":"10.3892\/etm.2021.10798"},{"key":"2026090816575600841_j_med-2026-1479_ref_046","doi-asserted-by":"crossref","unstructured":"Wang, J, Koch, DT, Hofmann, FO, H\u00e4rtwig, D, Beirith, I, Janssen, KP, et al.. WNT enhancing signals in pancreatic cancer are transmitted by LGR6. Aging (Albany NY) 2023;15:10897\u2013914. https:\/\/doi.org\/10.18632\/aging.205101.","DOI":"10.18632\/aging.205101"},{"key":"2026090816575600841_j_med-2026-1479_ref_047","doi-asserted-by":"crossref","unstructured":"Srivastava, A, Rikhari, D, Srivastava, S. RSPO2 as Wnt signaling enabler: important roles in cancer development and therapeutic opportunities. Genes Dis 2024;11:788\u2013806. https:\/\/doi.org\/10.1016\/j.gendis.2023.01.013.","DOI":"10.1016\/j.gendis.2023.01.013"},{"key":"2026090816575600841_j_med-2026-1479_ref_048","doi-asserted-by":"crossref","unstructured":"Longhitano, L, Vicario, N, Tibullo, D, Giallongo, C, Broggi, G, Caltabiano, R, et al.. Lactate induces the expressions of MCT1 and HCAR1 to promote tumor growth and progression in glioblastoma. Front Oncol 2022;12:871798. https:\/\/doi.org\/10.3389\/fonc.2022.871798.","DOI":"10.3389\/fonc.2022.871798"},{"key":"2026090816575600841_j_med-2026-1479_ref_049","doi-asserted-by":"crossref","unstructured":"Yu, S, Wu, Y, Li, C, Qu, Z, Lou, G, Guo, X, et al.. Comprehensive analysis of the SLC16A gene family in pancreatic cancer via integrated bioinformatics. Sci Rep 2020;10:7315. https:\/\/doi.org\/10.1038\/s41598-020-64356-y.","DOI":"10.1038\/s41598-020-64356-y"},{"key":"2026090816575600841_j_med-2026-1479_ref_050","doi-asserted-by":"crossref","unstructured":"Ruggiero, C, Fragassi, G, Grossi, M, Picciani, B, Di Martino, R, Capitani, M, et al.. A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation. Oncotarget 2015;6:3375\u201393. https:\/\/doi.org\/10.18632\/oncotarget.3270.","DOI":"10.18632\/oncotarget.3270"},{"key":"2026090816575600841_j_med-2026-1479_ref_051","doi-asserted-by":"crossref","unstructured":"Meng, X, Li, W, Yuan, H, Dong, W, Xiao, W, Zhang, X. KDELR2-KIF20A axis facilitates bladder cancer growth and metastasis by enhancing Golgi-mediated secretion. Biol Proced Online 2022;24:12. https:\/\/doi.org\/10.1186\/s12575-022-00174-y.","DOI":"10.1186\/s12575-022-00174-y"},{"key":"2026090816575600841_j_med-2026-1479_ref_052","doi-asserted-by":"crossref","unstructured":"Mao, H, Nian, J, Wang, Z, Li, X, Huang, C. KDELR2 is an unfavorable prognostic biomarker and regulates CCND1 to promote tumor progression in glioma. Pathol Res Pract 2020;216:152996. https:\/\/doi.org\/10.1016\/j.prp.2020.152996.","DOI":"10.1016\/j.prp.2020.152996"},{"key":"2026090816575600841_j_med-2026-1479_ref_053","doi-asserted-by":"crossref","unstructured":"Liao, Z, She, C, Ma, L, Sun, Z, Li, P, Zhang, X, et al.. KDELR2 promotes glioblastoma tumorigenesis targeted by HIF1a via mTOR signaling pathway. Cell Mol Neurobiol 2019;39:1207\u201315. https:\/\/doi.org\/10.1007\/s10571-019-00715-2.","DOI":"10.1007\/s10571-019-00715-2"},{"key":"2026090816575600841_j_med-2026-1479_ref_054","doi-asserted-by":"crossref","unstructured":"Ding, X, Deng, G, Liu, J, Liu, B, Yuan, F, Yang, X, et al.. GOLM1 silencing inhibits the proliferation and motility of human glioblastoma cells via the Wnt\/\u03b2-catenin signaling pathway. Brain Res 2019;1717:117\u201326. https:\/\/doi.org\/10.1016\/j.brainres.2019.03.035.","DOI":"10.1016\/j.brainres.2019.03.035"},{"key":"2026090816575600841_j_med-2026-1479_ref_055","doi-asserted-by":"crossref","unstructured":"Zhang, B, Wan, W, Li, Z, Gao, Z, Ji, N, Xie, J, et al.. A prognostic risk model for glioma patients by systematic evaluation of genomic variations. iScience 2022;25:105681. https:\/\/doi.org\/10.1016\/j.isci.2022.105681.","DOI":"10.1016\/j.isci.2022.105681"},{"key":"2026090816575600841_j_med-2026-1479_ref_056","unstructured":"Mehta, VV. The combination of cucurbitacin B and evodiamine induces apoptosis and inhibits cell propagation in glioma cells. Long Island University; 2023."},{"key":"2026090816575600841_j_med-2026-1479_ref_057","doi-asserted-by":"crossref","unstructured":"Jia, J, Chu, L, Zeng, X, Long, N, Dong, M, Yang, Y, et al.. GOLPH3 promotes vasculogenic mimicry via the epithelial mesenchymal transition in glioblastoma cells. Turk Neurosurg 2023;33:722\u201330. https:\/\/doi.org\/10.5137\/1019-5149.Jtn.34807-21.2.","DOI":"10.5137\/1019-5149.JTN.34807-21.2"},{"key":"2026090816575600841_j_med-2026-1479_ref_058","doi-asserted-by":"crossref","unstructured":"Miao, X, Leng, X, Zhang, Q. The current state of nanoparticle-induced macrophage polarization and reprogramming research. Int J Mol Sci 2017;18:336. https:\/\/doi.org\/10.3390\/ijms18020336.","DOI":"10.3390\/ijms18020336"},{"key":"2026090816575600841_j_med-2026-1479_ref_059","doi-asserted-by":"crossref","unstructured":"Chen, Z, Hambardzumyan, D. Immune microenvironment in glioblastoma subtypes. Front Immunol 2018;9:1004. https:\/\/doi.org\/10.3389\/fimmu.2018.01004.","DOI":"10.3389\/fimmu.2018.01004"},{"key":"2026090816575600841_j_med-2026-1479_ref_060","doi-asserted-by":"crossref","unstructured":"Komohara, Y, Horlad, H, Ohnishi, K, Fujiwara, Y, Bai, B, Nakagawa, T, et al.. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 2012;103:2165\u201372. https:\/\/doi.org\/10.1111\/cas.12015.","DOI":"10.1111\/cas.12015"},{"key":"2026090816575600841_j_med-2026-1479_ref_061","doi-asserted-by":"crossref","unstructured":"Chen, W, Zhao, Y, Li, XC, Kubiak, JZ, Ghobrial, RM, Kloc, M. Rho-specific Guanine nucleotide exchange factors (Rho-GEFs) inhibition affects macrophage phenotype and disrupts Golgi complex. Int J Biochem Cell Biol 2017;93:12\u201324. https:\/\/doi.org\/10.1016\/j.biocel.2017.10.009.","DOI":"10.1016\/j.biocel.2017.10.009"},{"key":"2026090816575600841_j_med-2026-1479_ref_062","doi-asserted-by":"crossref","unstructured":"Curran, CS, Evans, MD, Bertics, PJ. GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation. J\u00a0Immunol 2011;187:1254\u201363. https:\/\/doi.org\/10.4049\/jimmunol.1001965.","DOI":"10.4049\/jimmunol.1001965"},{"key":"2026090816575600841_j_med-2026-1479_ref_063","doi-asserted-by":"crossref","unstructured":"Yu, F, Lou, S, He, H, Zhou, Y. Potential role of POFUT1 as a prognostic predictor in low-grade gliomas: immune microenvironment insights from a pan-cancer analysis. Heliyon 2024;10:e27004. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27004.","DOI":"10.1016\/j.heliyon.2024.e27004"},{"key":"2026090816575600841_j_med-2026-1479_ref_064","doi-asserted-by":"crossref","unstructured":"Chen, X, Tian, F, Wu, Z. A genomic instability-associated prognostic signature for glioblastoma patients. World Neurosurg 2022;167:e515\u201326. https:\/\/doi.org\/10.1016\/j.wneu.2022.08.049.","DOI":"10.1016\/j.wneu.2022.08.049"},{"key":"2026090816575600841_j_med-2026-1479_ref_065","doi-asserted-by":"crossref","unstructured":"Friedmann-Morvinski, D, Hambardzumyan, D. Monocyte-neutrophil entanglement in glioblastoma. J\u00a0Clin Investig 2023;133:e163451. https:\/\/doi.org\/10.1172\/jci163451.","DOI":"10.1172\/JCI163451"},{"key":"2026090816575600841_j_med-2026-1479_ref_066","doi-asserted-by":"crossref","unstructured":"Huang, S, Song, Z, Zhang, T, He, X, Huang, K, Zhang, Q, et al.. Identification of immune cell infiltration and immune-related genes in the tumor microenvironment of glioblastomas. Front Immunol 2020;11:585034. https:\/\/doi.org\/10.3389\/fimmu.2020.585034.","DOI":"10.3389\/fimmu.2020.585034"},{"key":"2026090816575600841_j_med-2026-1479_ref_067","doi-asserted-by":"crossref","unstructured":"Rodrigues, JC, Gonzalez, GC, Zhang, L, Ibrahim, G, Kelly, JJ, Gustafson, MP, et al.. Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol 2010;12:351\u201365. https:\/\/doi.org\/10.1093\/neuonc\/nop023.","DOI":"10.1093\/neuonc\/nop023"},{"key":"2026090816575600841_j_med-2026-1479_ref_068","doi-asserted-by":"crossref","unstructured":"Yang, Y, Zhang, RL, Yang, ZF, Liu, Q, Cai, C, Zhang, H, et al.. An experimental study on roles of GP73 and PI3K\/Akt pathway in the Sorafenib resistant mechanism in patients with hepatocellular carcinoma. Chin J Gen Pract 2019;17:6. https:\/\/doi.org\/10.16766\/j.cnki.issn.1674-4152.000585.","DOI":"10.1186\/s12943-018-0872-3"},{"key":"2026090816575600841_j_med-2026-1479_ref_069","doi-asserted-by":"crossref","unstructured":"Liu, Y, Wang, J, Yang, R, Cheng, Y, Zhou, Y, Li, H, et al.. GP73-mediated secretion of AFP and GP73 promotes proliferation and metastasis of hepatocellular carcinoma cells. Oncogenesis 2021;10:69. https:\/\/doi.org\/10.1038\/s41389-021-00358-3.","DOI":"10.1038\/s41389-021-00358-3"},{"key":"2026090816575600841_j_med-2026-1479_ref_070","doi-asserted-by":"crossref","unstructured":"Gao, Y, Yin, Z, Qi, Y, Peng, H, Ma, W, Wang, R, et al.. Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p. Cancer Cell Int 2022;22:35. https:\/\/doi.org\/10.1186\/s12935-022-02462-9.","DOI":"10.1186\/s12935-022-02462-9"},{"key":"2026090816575600841_j_med-2026-1479_ref_071","doi-asserted-by":"crossref","unstructured":"Guo, SB, Meng, Y, Lin, L, Zhou, ZZ, Li, HL, Tian, XP, et al.. Artificial intelligence alphafold model for molecular biology and drug discovery: a machine-learning-driven informatics investigation. Mol Cancer 2024;23:223. https:\/\/doi.org\/10.1186\/s12943-024-02140-6.","DOI":"10.1186\/s12943-024-02140-6"},{"key":"2026090816575600841_j_med-2026-1479_ref_072","doi-asserted-by":"crossref","unstructured":"Guo, SB, Liu, DY, Fang, XJ, Meng, Y, Zhou, ZZ, Li, J, et al.. Current concerns and future directions of large language model ChatGPT in medicine: a machine-learning-driven global-scale bibliometric analysis. Int J Surg 2026;112:2805\u201322. https:\/\/doi.org\/10.1097\/js9.0000000000003668.","DOI":"10.1097\/JS9.0000000000003668"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1479\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1479\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:58:18Z","timestamp":1788886698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2026-1479\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,8]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/med-2026-1479"],"URL":"https:\/\/doi.org\/10.1515\/med-2026-1479","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20261479"}}